ROP vs RVPH · P/E 41, rev $4.20B vs $7.6M cap
Roper Technologies, Inc. (ROP) versus Reviva Pharmaceuticals Holdings Inc. (RVPH) — a side-by-side from cached financials, not a winner call.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Reviva Pharmaceuticals Holdings Inc. (RVPH) is a biotechnology company listed on NASDAQ.
Latest reported ROP revenue for 2026-06-30 was $4.20B. Net income was $1.68B. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
RVPH does not have a complete income-statement cache yet.
ROP currently screens at market cap $61.61B and trailing P/E 41.3. RVPH currently screens at market cap $7.6M.
Not investment advice. Open the ROP and RVPH stock pages for the full models.
Not investment advice.